文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

狂犬病预防措施的成本效果模型研究:系统综述

Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review.
PubMed 文献 · Vaccine · 2018-12-13

该研究系统检索MEDLINE和SCOPUS,纳入17项狂犬病预防措施成本效果模型研究,聚焦暴露后预防(PEP)、暴露前预防(PrEP)可及性提升及大规模犬只疫苗接种场景。结果显示在狂犬病流行国家,干预相比无干预在人均GDP 1-3倍阈值下具成本效果,但PEP因评估时限较短而每避免DALY或获得QALY的成本低于犬只疫苗接种。

要点

  • 在流行国家,狂犬病预防干预在人均GDP 1-3倍阈值下具成本效果
  • PEP因一年时限评估,每避免DALY成本低于4-10年时限的犬只疫苗接种
  • 决策树模型路径相似,报告质量总体较高但内部真实性有待改进

核心结论

  • 在狂犬病流行国家,预防干预相比无干预在人均GDP 1-3倍成本效果阈值下具成本效果。
  • PEP因一年时限评估,每避免DALY或获得QALY的成本低于4-10年时限的犬只疫苗接种。

研究设计与样本

  • 系统综述,检索MEDLINE和SCOPUS,纳入17项成本效果模型研究。
  • 研究多聚焦提升PEP和PrEP可及性、仅大规模犬只疫苗接种或联合PEP策略的人类狂犬病消除场景。

主要发现

  • 未发现显著方法学不一致,报告程度总体较高,但质量与内部真实性有改进点。
  • 决策树模型路径相似。
  • PEP每避免DALY或获得QALY的成本低于犬只疫苗接种,因评估时限分别为一年与4或10年。

关键数值与推荐

  • 成本效果阈值为人均GDP的1至3倍(依据宏观经济与健康委员会推荐)。
  • 比较指标包括每获得QALY或每避免DALY的增量成本效果比(ICER),以购买力平价转换的国际元表示。

临床怎么用

  • 在狂犬病流行国家,可将PEP和犬只疫苗接种作为具成本效果的预防策略。
  • 决策时需注意PEP与犬只疫苗接种的评估时限差异对成本效果比较的影响。
  • 模型选择可参考决策树路径,但需关注内部真实性改进点。

局限性

  • 未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rabies is one of the most feared infectious diseases worldwide, predominantly occurring in Asia and Africa where rabies is endemic in domestic dog populations. Whereas previous studies have demonstrated mass dog vaccination and post-exposure prophylaxis (PEP) as the most effective control strategies, successful rabies elimination has yet to be realized as these recognized effective interventions continue to face challenges of limited accessibility. In the light of new evidence towards improving programmatic feasibility and clinical practice in rabies control especially among endemic countries, a systematic review was undertaken to identify cost-effectiveness modelling studies of rabies preventive measures and to provide a critical review of published evidence through comparative evaluation and model quality assessment, and a synthesis of key findings based thereon. Our search through MEDLINE and SCOPUS identified a total of 17 studies which mostly focused on estimating the impact of increasing PEP and pre-exposure prophylaxis (PrEP) access, human rabies elimination scenarios using mass dog vaccinations only or complemented with PEP strategy. While no significant methodological inconsistency across studies was identified and the extent of reporting is generally high, we note several points for quality and internal validity improvement. Assessment of modelling approach showed that decision tree models had similar pathways. The results of the studies suggest that interventions would be cost-effective at the cost-effectiveness threshold of 1 to 3 times per capita Gross Domestic Product (GDP) as recommended by the Commission on Macroeconomics and Health's GDP based thresholds, compared with no intervention in rabies endemic countries. When compared across studies which reported incremental cost-effectiveness ratio (ICER) as cost per QALY gained or DALY averted in international dollars adjusted by purchasing power parity conversion rate, PEP vaccination yields less cost per DALY averted or QALY gained due to one year-horizon assessment compared to canine vaccination at 4- or 10-year-time horizon.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Anothaisintawee T, Julienne Genuino A, Thavorncharoensap M, et al. Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review. Vaccine. 2018. PMID: 30554795. doi:10.1016/j.vaccine.2018.11.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。